AG˹ٷ

STOCK TITAN

[144] Cameco Corporation SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Cameco Corporation (CCJ) submitted a Form 144 reporting a proposed sale of 500 common shares with an aggregate market value of 36,170.00, to be sold approximately on 06/24/2025 on the NYSE through BMO Investorline.

The filing shows those shares were acquired by open-market purchases on 11/04/2014 (400 shares) and 11/06/2014 (100 shares), paid in cash. It lists total shares outstanding of 435,387,448 and records a sale of 500 shares on 06/23/2025 with gross proceeds of 34,860.00. The seller certifies they are unaware of any undisclosed material adverse information.

Cameco Corporation (CCJ) ha depositato un Modulo 144 segnalando il previsto vendita di 500 azioni ordinarie con un valore di mercato complessivo di 36,170.00, da realizzarsi indicativamente il 06/24/2025 sulla NYSE tramite BMO Investorline.

La comunicazione indica che tali azioni sono state acquisite tramite acquisti sul mercato aperto il 11/04/2014 (400 azioni) e il 11/06/2014 (100 azioni), pagate in contanti. Riporta un totale di azioni in circolazione pari a 435,387,448 e registra la vendita di 500 azioni in data 06/23/2025 con proventi lordi di 34,860.00. Il venditore dichiara di non essere a conoscenza di informazioni materialmente sfavorevoli non divulgate.

Cameco Corporation (CCJ) presentó un Formulario 144 informando sobre la venta propuesta de 500 acciones ordinarias con un valor de mercado agregado de 36,170.00, que se venderían aproximadamente el 06/24/2025 en la NYSE a través de BMO Investorline.

La presentación muestra que esas acciones fueron adquiridas mediante compras en el mercado abierto el 11/04/2014 (400 acciones) y el 11/06/2014 (100 acciones), pagadas en efectivo. Indica un total de acciones en circulación de 435,387,448 y registra una venta de 500 acciones el 06/23/2025 con ingresos brutos de 34,860.00. El vendedor certifica que no tiene conocimiento de información adversa material no divulgada.

Cameco Corporation (CCJ)Form 144� 제출하여 � 시장갶� 36,170.00보통� 500�� 대� 06/24/2025NYSE에서 BMO Investorline� 통해 매각� 예정임을 보고했습니다.

신고서에� 해당 주식� 11/04/2014(400�) � 11/06/2014(100�)� 장내 매수� 취득되었� 현금으로 결제되었다고 기재되어 있습니다. � 발행주식 수를 435,387,448� 기재했으� 06/23/2025� 500주를 매도� 총수�(브루�) 34,860.00� 기록� 것으� 나와 있습니다. 매도인은 공개되지 않은 중대� 불리� 정보갶 없음� 확인합니�.

Cameco Corporation (CCJ) a déposé un formulaire 144 signalant la vente prévue de 500 actions ordinaires d'une valeur marchande totale de 36,170.00, devant être vendues aux alentours du 06/24/2025 sur la NYSE via BMO Investorline.

Le dossier indique que ces actions ont été acquises sur le marché libre le 11/04/2014 (400 actions) et le 11/06/2014 (100 actions), payées en espèces. Il mentionne un total d'actions en circulation de 435,387,448 et enregistre une vente de 500 actions le 06/23/2025 pour un produit brut de 34,860.00. Le vendeur certifie ne pas avoir connaissance d'informations défavorables importantes non divulguées.

Cameco Corporation (CCJ) reichte ein Formular 144 ein, das den geplanten Verkauf von 500 Stammaktien mit einem aggregierten Marktwert von 36,170.00 meldet, der voraussichtlich am 06/24/2025 an der NYSE ü BMO Investorline erfolgen soll.

Die Einreichung zeigt, dass diese Aktien am 11/04/2014 (400 Aktien) und am 11/06/2014 (100 Aktien) durch offene Marktkäufe und in bar erworben wurden. Es werden insgesamt 435,387,448 ausstehende Aktien angegeben, und es wird ein Verkauf von 500 Aktien am 06/23/2025 mit Bruttoerlösen von 34,860.00 verzeichnet. Der Verkäufer bestätigt, dass ihm keine nicht offengelegten, wesentlich nachteiligen Informationen bekannt sind.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Form 144 notifies a small, likely immaterial sale of 500 CCJ shares versus 435.4M outstanding, so market impact is minimal.

The notice documents a proposed sale of 500 common shares valued at 36,170.00, to be executed via BMO Investorline on the NYSE around 06/24/2025. Relative to the 435,387,448 shares outstanding, the size is de minimis and unlikely to affect liquidity or share price. The filing follows standard disclosure practice for restricted or control-holder sales and includes prior acquisition dates in 2014, indicating long-term holding before the sale.

TL;DR: Disclosure appears routine; seller affirms no undisclosed adverse information, so governance implications are limited.

The form includes the required representation that the seller does not possess material nonpublic adverse information, and it documents acquisition method (open-market purchases in 2014) and payment in cash. The presence of a near-term executed sale on 06/23/2025 with proceeds reported suggests compliance with reporting obligations. There are no indications of insider trading plans referenced or governance concerns disclosed within this filing.

Cameco Corporation (CCJ) ha depositato un Modulo 144 segnalando il previsto vendita di 500 azioni ordinarie con un valore di mercato complessivo di 36,170.00, da realizzarsi indicativamente il 06/24/2025 sulla NYSE tramite BMO Investorline.

La comunicazione indica che tali azioni sono state acquisite tramite acquisti sul mercato aperto il 11/04/2014 (400 azioni) e il 11/06/2014 (100 azioni), pagate in contanti. Riporta un totale di azioni in circolazione pari a 435,387,448 e registra la vendita di 500 azioni in data 06/23/2025 con proventi lordi di 34,860.00. Il venditore dichiara di non essere a conoscenza di informazioni materialmente sfavorevoli non divulgate.

Cameco Corporation (CCJ) presentó un Formulario 144 informando sobre la venta propuesta de 500 acciones ordinarias con un valor de mercado agregado de 36,170.00, que se venderían aproximadamente el 06/24/2025 en la NYSE a través de BMO Investorline.

La presentación muestra que esas acciones fueron adquiridas mediante compras en el mercado abierto el 11/04/2014 (400 acciones) y el 11/06/2014 (100 acciones), pagadas en efectivo. Indica un total de acciones en circulación de 435,387,448 y registra una venta de 500 acciones el 06/23/2025 con ingresos brutos de 34,860.00. El vendedor certifica que no tiene conocimiento de información adversa material no divulgada.

Cameco Corporation (CCJ)Form 144� 제출하여 � 시장갶� 36,170.00보통� 500�� 대� 06/24/2025NYSE에서 BMO Investorline� 통해 매각� 예정임을 보고했습니다.

신고서에� 해당 주식� 11/04/2014(400�) � 11/06/2014(100�)� 장내 매수� 취득되었� 현금으로 결제되었다고 기재되어 있습니다. � 발행주식 수를 435,387,448� 기재했으� 06/23/2025� 500주를 매도� 총수�(브루�) 34,860.00� 기록� 것으� 나와 있습니다. 매도인은 공개되지 않은 중대� 불리� 정보갶 없음� 확인합니�.

Cameco Corporation (CCJ) a déposé un formulaire 144 signalant la vente prévue de 500 actions ordinaires d'une valeur marchande totale de 36,170.00, devant être vendues aux alentours du 06/24/2025 sur la NYSE via BMO Investorline.

Le dossier indique que ces actions ont été acquises sur le marché libre le 11/04/2014 (400 actions) et le 11/06/2014 (100 actions), payées en espèces. Il mentionne un total d'actions en circulation de 435,387,448 et enregistre une vente de 500 actions le 06/23/2025 pour un produit brut de 34,860.00. Le vendeur certifie ne pas avoir connaissance d'informations défavorables importantes non divulguées.

Cameco Corporation (CCJ) reichte ein Formular 144 ein, das den geplanten Verkauf von 500 Stammaktien mit einem aggregierten Marktwert von 36,170.00 meldet, der voraussichtlich am 06/24/2025 an der NYSE ü BMO Investorline erfolgen soll.

Die Einreichung zeigt, dass diese Aktien am 11/04/2014 (400 Aktien) und am 11/06/2014 (100 Aktien) durch offene Marktkäufe und in bar erworben wurden. Es werden insgesamt 435,387,448 ausstehende Aktien angegeben, und es wird ein Verkauf von 500 Aktien am 06/23/2025 mit Bruttoerlösen von 34,860.00 verzeichnet. Der Verkäufer bestätigt, dass ihm keine nicht offengelegten, wesentlich nachteiligen Informationen bekannt sind.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What securities is Cameco (CCJ) proposing to sell in this Form 144?

The filing proposes the sale of 500 common shares with an aggregate market value of 36,170.00, to be sold approximately on 06/24/2025 on the NYSE.

Who is listed as a recent seller related to this Form 144 for CCJ?

The filings list Catherine Gignac as a seller who sold 500 common shares on 06/23/2025 for gross proceeds of 34,860.00.

How and when were the shares being sold originally acquired?

The shares were acquired via open-market purchases, specifically 400 shares on 11/04/2014 and 100 shares on 11/06/2014, paid in cash.

Through which broker and exchange will the CCJ shares be sold?

The broker listed is BMO Investorline (100 King St W, Toronto) and the intended exchange is the NYSE.

How many CCJ shares are outstanding according to this filing?

The filing lists 435,387,448 shares outstanding.

Does the seller make any certification about material information?

Yes, the person for whose account the securities are to be sold represents they do not know any material adverse information about the issuer that has not been publicly disclosed.
Cameco

NYSE:CCJ

CCJ Rankings

CCJ Latest News

CCJ Latest SEC Filings

CCJ Stock Data

33.31B
433.52M
0.14%
73.32%
4.06%
Uranium
Energy
Canada
Saskatoon